deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 3-arm NCT02866136

Conservative Treatments of Retinoblastoma (RETINO2011)

Sponsor: Fondation Rothschild Paris

Conditions Children Retinal Neoplasm Retinoblastoma
Interventions Carboplatin + laser day 1 (chemothermotherapy) I125 radioactive plaques (local treatment) Laser (local treatment) Melphalan VP16, carboplatin VP16, carboplatin, vincristin cryoapplication (local treatment) intravitreal Melphalan (local treatment)
Updated 10 times since 2017 Last updated: Nov 21, 2025 Started: Feb 29, 2012 Primary completion: Jan 31, 2023 Completion: Sep 30, 2035
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02866136, this PHASE2 trial focuses on Children and Retinal Neoplasm and remains ongoing. Sponsored by Fondation Rothschild Paris, it has been updated 10 times since 2012, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotRecruiting~Apr 2019 – ~Sep 2020 · 17 months · monthly snapshotRecruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2023 · 26 months · monthly snapshotRecruiting~Mar 2023 – ~Feb 2024 · 11 months · monthly snapshotActive Not Recruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Dec 2025 · 15 months · monthly snapshotActive Not Recruiting~Dec 2025 – present · 7 months · monthly snapshotActive Not Recruiting

Change History

10 versions recorded

  1. Dec 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2024 — Dec 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Mar 2023 — Feb 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

▶ Show 5 earlier versions

  1. Jan 2021 — Mar 2023 [monthly]

    Recruiting PHASE2

  2. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  3. Apr 2019 — Sep 2020 [monthly]

    Recruiting PHASE2

  4. Jun 2018 — Apr 2019 [monthly]

    Recruiting PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fondation Rothschild Paris
  • Institut Curie
Data source: Institut Curie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations